Skip to main content

Table 4 Plasma dietary α-tocopherol, carotenoids and polyphenols

From: Bilberry/red grape juice decreases plasma biomarkers of inflammation and tissue damage in aged men with subjective memory impairment –a randomized clinical trial

 

Bilberry/red grape juice (n = 30)

Placebo-juice (n = 30)

 

Baseline

Post-intervention

Baseline

Post intervention

pMW(Change)

α-tocopherol (μM)

31.4

(29.0–35.6)

30.0

(27.0–32.4)

30.5

(27.1–32.2)

28.8

(25.7–31.2)

0.38

Carotenoids

 lutein (μM)

0.24

(0.21–0.30)

0.22

(0.19–0.30)

0.26

(0.22–0.28)

0.27

(0.20–0.31)

0.04*

 zeaxanthin (μM)

0.06

(0.05–0.08)

0.61

(0.04–0.07)

0.06

(0.06–0.08)

0.06

(0.05–0.07)

0.52

 β-cryp (μM)

0.30

(0.23–0.38)

0.16

(0.12–0.26)

0.26

(0.20–0.38)

0.13

(0.09–0.20)

0.57

 α-caroten (μM)

0.09

(0.52–0.13)

0.07

(0.05–0.10)

0.08

(0.05–0.12)

0.08

(0.04–0.09)

0.94

 β-caroten (μM)

0.49

(0.33–0.73)

0.37

(0.30–0.50)

0.39

(0.30–0.73)

0.35

(0.26–0.62)

0.80

 lycopen (μM)

0.55

(0.43–0.68)

0.53

(0.39–0.65)

0.57

(0.43–0.66)

0.51

(0.35–0.58)

0.21

Polyphenols

 Quercetin (nmol/L)

10.2

(5.2–14.8)

18.8

(11.6–24.8)

13.7

(8.1.-26.1)

10.2

(7.1–20.1)

0.27

 3HPAA (nmol/L)

133.0

(85.1–178.8)

219.0

(148.0–268.7)

173.7

(107.3–244.7)

118.1

(68.8–153.2)

< 0.01**

 33HPPA (nmol/L)

257.1

(104.0–569.0)

166.6

(75.9–266.2)

230.0

(89.7–350.2)

198.5

(107.1–437.1)

0.07

 Vanillic acid (nmol/L)

41.2

(32.9–47.5)

44.3

(34.8–66.2)

41.5

(31.4–65.8)

44.4

(30.7–52.8)

0.03*

 Protocatechuic acid (nmol/L)

30.8

(26.4–33.1)

42.0

(33.5–48.7)

36.7

(31.23–45.71)

30.2

(26.4–38.36)

< 0.01**

 HVA (nmol/L)

65.8

(60.4–80.0)

89.7

(63.0–104.5)

61.0

(54.4–92.3)

63.9

(55.9–88.2

0.08

 DOPAC (nmol/L)

98.7

(87.8–118.0)

125.3

(99.0–138.6)

105.1

(94.7–132.5)

112.3

(107.5–134.7)

0.28

 Gallic acid (nmol/L)

4.3

(3.4–6.3)

4.5

(3.3–5.3)

5.3

(3.7–6.7)

4.8

(2.9–6.2)

0.46

 DHCA (nmol/L)

24.1

(16.9–45.0)

26.7

(16.7–43.4)

40.3

(17.6–51.8)

26.7

(21.8–48.0)

0.81

 p-Coumaric acid (nmol/L)

2.2

(1.0–5.5)

4.7

(2.8–8.0)

2.7

(1.3–5.9)

3.5

(2.6–5.0)

< 0.01**

 Caffeic acid (nmol/L)

33.5

(20.6–38.2)

33.9

(24.4–46.8)

34.6

(24.4–55.6)

29.1

(17.1–45.9)

0.10

 Ferulic acid (nmol/L)

23.6

(20.3–29.1)

22.0

(17.4–27.8)

24.5

(17.0–45.6)

18.1

(14.9–25.9)

0.18

 Enterolactone (nmol/L)

17.5

(13.6–26.3)

25.6

(17.45–39.1)

30.7

(20.8–50.1)

30.7

(17.2–41.7)

0.06

 Hippuric acid (nmol/L)

1674

(1185–2186)

2503.7

(1650–4442)

1354

(943–2380)

1367

(855–2504)

0.05*

 Paraxanthine (μmol/L)

3.0

(1.8–4.6)

2.9

(2.0–5.6)

3.8

(2.0–5.3)

4.2

(2.7–6.2)

0.14

  1. Data are presented as baseline median or median to post-intervention with corresponding 95%CL (lower, upper). pMW(change) was obtained comparing the groups with regards to change using Mann Whitney test. 33HPPA 3-(3-hydroxyphenyl)-propionic acid, 3HPAA 3-hydroxyphenylacetic acid, HVA Homovanillic acid/4-hydroxy-3-methoxyphenylacetic acid, DOPAC 3,4-dihydroxyphenylacetic acid, DHCA Dihydrocaffeic acid, PA Protocatechuic acid. **Paraxanthine is a methylxanthine. *p ≤ 0.05, **p < 0.001